Home NDC 51672-2085-01 NDC 51672-2085-01 - Childrens Loratadine This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 51672-2085
Requested NDC 51672-2085-01
Package NDCs from labels 51672-2085-8, 51672-2085-4, 51672-2085-5, 51672-2085-1, 51672-2085-01
Manufacturer Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd.
Effective date 2026-07-14
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 51672-2085-1 Childrens Loratadine 1 in 1 CARTON SOLUTION 1 4 51672-2085-1 Childrens Loratadine 240 mL in 1 BOTTLE SOLUTION 240 4 51672-2085-4 Childrens Loratadine 1 in 1 CARTON SOLUTION 1 4 51672-2085-4 Childrens Loratadine 60 mL in 1 BOTTLE SOLUTION 60 4 51672-2085-5 Childrens Loratadine 180 mL in 1 BOTTLE SOLUTION 180 4 51672-2085-5 Childrens Loratadine 1 in 1 CARTON SOLUTION 1 4 51672-2085-8 Childrens Loratadine 120 mL in 1 BOTTLE SOLUTION 120 4 51672-2085-8 Childrens Loratadine 1 in 1 CARTON SOLUTION 1 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51672-2085 CHILDRENS LORATADINE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] 4 Current NDC, Legacy NDC, 8 package rows 20241222_12c8066a-3429-481e-b63a-7ea2b439a170.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Loratadine ACTIVE INGREDIENT 7AJO3BO7QN CHILDRENS LORATADINE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] 2 Loratadine ACTIVE MOIETY 7AJO3BO7QN CHILDRENS LORATADINE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] 2 citric acid monohydrate INACTIVE INGREDIENT 2968PHW8QP CHILDRENS LORATADINE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] 2 glycerin INACTIVE INGREDIENT PDC6A3C0OX CHILDRENS LORATADINE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] 2 propylene glycol INACTIVE INGREDIENT 6DC9Q167V3 CHILDRENS LORATADINE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] 2 sodium benzoate INACTIVE INGREDIENT OJ245FE5EU CHILDRENS LORATADINE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] 2 sodium metabisulfite INACTIVE INGREDIENT 4VON5FNS3C CHILDRENS LORATADINE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] 2 sucrose INACTIVE INGREDIENT C151H8M554 CHILDRENS LORATADINE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] 2 water INACTIVE INGREDIENT 059QF0KO0R CHILDRENS LORATADINE (LORATADINE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] 2 LORATADINE ACTIVE INGREDIENT 7AJO3BO7QN CHILDRENS LORATADINE (LORATADINE) SOLUTION [AIDAREX PHARMACEUTICALS LLC] 1 LORATADINE ACTIVE MOIETY 7AJO3BO7QN CHILDRENS LORATADINE (LORATADINE) SOLUTION [AIDAREX PHARMACEUTICALS LLC] 1 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP CHILDRENS LORATADINE (LORATADINE) SOLUTION [AIDAREX PHARMACEUTICALS LLC] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX CHILDRENS LORATADINE (LORATADINE) SOLUTION [AIDAREX PHARMACEUTICALS LLC] 1 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 CHILDRENS LORATADINE (LORATADINE) SOLUTION [AIDAREX PHARMACEUTICALS LLC] 1 SODIUM BENZOATE INACTIVE INGREDIENT OJ245FE5EU CHILDRENS LORATADINE (LORATADINE) SOLUTION [AIDAREX PHARMACEUTICALS LLC] 1 SODIUM METABISULFITE INACTIVE INGREDIENT 4VON5FNS3C CHILDRENS LORATADINE (LORATADINE) SOLUTION [AIDAREX PHARMACEUTICALS LLC] 1 SUCROSE INACTIVE INGREDIENT C151H8M554 CHILDRENS LORATADINE (LORATADINE) SOLUTION [AIDAREX PHARMACEUTICALS LLC] 1 WATER INACTIVE INGREDIENT 059QF0KO0R CHILDRENS LORATADINE (LORATADINE) SOLUTION [AIDAREX PHARMACEUTICALS LLC] 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 10 of 52 · 1,039 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Loratadine Allergy Relief LORATADINE A-S Medication Solutions a53e5635-8633-4c28-b04f-cdfb3d851e68 2026-02-19 Warnings Exact identifier unii: 7AJO3BO7QN Berkley and Jensen Allergy Relief LORATADINE BJWC e981a0ef-08e9-4ac3-92a1-411217e0a251 2026-02-16 Warnings Exact identifier unii: 7AJO3BO7QN WowDay Hemorrhoid and Fissure Cream HEMORRHOID AND FISSURE CREAM WowDay LLC 47ba86ad-240a-e733-e063-6394a90a24e3 2026-02-12 Warnings Exact identifier unii: PDC6A3C0OX Viva Hydration Boost GLYCERIN Nomax Inc 174193b2-65eb-b5fd-e063-6394a90a9cd0 2026-02-10 Warnings Exact identifier unii: PDC6A3C0OX Droptics Performance Eye Drops NAPHAZOLINE HYDROCHLORIDE, PROPYLENE GLYCOL Droptics LLC 20fd6822-a7fd-4593-92bb-0a07260893e2 2026-02-09 Warnings Exact identifier unii: 6DC9Q167V3 Loratadine LORATADINE Major Pharmaceuticals 60162446-4fa1-4ee3-ae20-19fadc2491ab 2026-02-09 Warnings Exact identifier unii: 7AJO3BO7QN Loratadine and Pseudoephedrine LORATADINE AND PSEUDOEPHEDRINE Sportpharm LLC 2b432b67-f9f3-45e2-8306-2d4080152f99 2026-02-06 Warnings Exact identifier unii: 7AJO3BO7QN loratadine D LORATADINE, PSEUDOEPHEDRINE SULFATE Sportpharm LLC bb54f613-b2ab-48fd-83c9-2038ec7097f6 2026-02-06 Warnings Exact identifier unii: 7AJO3BO7QN Childrens Loratadine Oral LORATADINE Atlantic Biologicals 4a1a6981-133c-d45b-e063-6294a90a4a09 2026-02-05 Warnings Exact identifier rxcui: 692783 unii: 7AJO3BO7QN Allergy Relief LORATADINE Kroger Company dac0b200-6b02-4c8a-b1dd-a4d5341dfb2d 2026-02-05 Warnings Exact identifier unii: 7AJO3BO7QN Optase GLYCERIN Scope Health Inc 376e0289-28e9-e87f-e063-6294a90a3b04 2026-01-30 Warnings Exact identifier unii: PDC6A3C0OX Optase GLYCERIN Scope Health Inc 10c3e31d-779d-8ff6-e063-6294a90acd39 2026-01-30 Warnings Exact identifier unii: PDC6A3C0OX Optase GLYCERIN Scope Health Inc 9e96976b-2990-79e0-e053-2995a90a0f29 2026-01-30 Warnings Exact identifier unii: PDC6A3C0OX Optase GLYCERIN Scope Health Inc d81c1a4f-87b0-ee8c-e053-2995a90af9e5 2026-01-30 Warnings Exact identifier unii: PDC6A3C0OX Optase GLYCERIN Scope Health Inc f452a2c4-c869-7bf5-e053-2995a90ac1a0 2026-01-30 Warnings Exact identifier unii: PDC6A3C0OX Additive Formula 3 DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE Terumo BCT, Ltd 9a5247a1-cc05-442d-b2d0-950f887f03c2 2026-01-30 Warnings, Adverse reactions Exact identifier unii: 2968PHW8QP Regener-Eyes Ophthalmic Solution LITE XL GLYCERIN OPHTHALMIC SOLUTION M & M PRODUCTS, L.L.C. 47ab9609-4291-30b2-e063-6394a90a421e 2026-01-29 Warnings Exact identifier unii: PDC6A3C0OX Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL GLYCERIN OPHTHALMIC SOLUTION M & M PRODUCTS, L.L.C. 48d6dc98-66e8-b499-e063-6394a90ae935 2026-01-29 Warnings Exact identifier unii: PDC6A3C0OX Loratadine LORATADINE Strategic Sourcing Services, LLC a527f83a-4ae9-47b1-94e0-7ab3148b025f 2026-01-29 Warnings Exact identifier unii: 7AJO3BO7QN Optase GLYCERIN Scope Health Inc 86c14327-ffc7-806e-e053-2991aa0aaf92 2026-01-29 Warnings Exact identifier unii: PDC6A3C0OX
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.